NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population

DNA and Cell Biology

Volumn 30, Issue 4, 2011, Pages 241-245

  Fan, Yaxin ^a   Yu, Weijian ^a   Ye, Ping ^a   Wang, Huali ^b   Wang, Zhongmin ^b   Meng, Qingli ^a   Duan, Ying ^a   Liang, Xiaohua ^a   An, Wanxin ^a  

^a Dalian Blood Center   (China)

^b Dalian Obstetrics and Gynecology Hospital ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR PROMOTER;

ADULT; ADVANCED CANCER; ARTICLE; CAPILLARY ELECTROPHORESIS; CARCINOGENESIS; CHINESE; DISEASE PREDISPOSITION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; MIDDLE AGED; NEOPLASM STAGING; NF-KAPPA B P50 SUBUNIT; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; YOUNG ADULT;

EID: 79953243447     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1107     Document Type: Article

References (35)

1. Annunziata, C.M., Stavnes, H.T., Kleinberg, L., Berner, A., Hernandez, L.F., Birrer, M.J., Steinberg, S.M., Davidson, B., and Kohn, E.C. (2010). Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer 116, 3276-3284.
2. Barkett, M., and Gilmore, T.D. (1999). Control of apoptosis by Rel/NF-kB transcriptionfactors. Oncogene 18, 6910-6924
3. Borm, M.E., van Bodegraven, A.A., Mulder, C.J., Kraal, G., and Bouma, G. (2005). A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 32, 401-405. (Pubitemid 41735580)
4. Chang, J., Bridgewater, J., and Gore, M. (1994). Non-surgical aspects of ovarian cancer. Lancet 343, 335-340. (Pubitemid 24043184)
5. Chen, F., Castranova, V., Shi, X., and Demers, L.M. (1999). New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45, 7-17. (Pubitemid 29036378)
6. Chen, F., Castranova, V., and Shi, X. (2001). New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159, 387-397. (Pubitemid 32751067)
7. Havrilesky, L., Darcy, M., Hamdan, H., Priore, R.L., Leon, J., Bell, J., and Berchuck, A. (2003). Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 21, 3814-3825. (Pubitemid 46606237)
8. Hernandez, L., Hsu, S., Davidson, B., Birrer, M.J., Kohn, E.C., and Annunziata, C.M. (2010). Activation of NF-kB signaling by IKKb increases aggressiveness of ovarian cancer. Cancer Res 70, 4005-4014.
9. Heron, E., Deloukas, P., and van Loon, A.P. (1995). The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction. Genomics 30, 493-505. (Pubitemid 26041490)
10. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J Clin 58, 71-96. (Pubitemid 351521864)
11. Karban, A.S., Okazaki, T., Panhuysen, C.I., Gallegos, T., Potter, J.J., Bailey-Wilson, J.E., Silverberg, M.S., Duerr, R.H., Cho, J.H., Gregersen, P.K., Wu, Y., Achkar, J.P., Dassopoulos, T., Mezey, E., Bayless, T.M., Nouvet, F.J., and Brant, S.R. (2004). Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13, 35-45. (Pubitemid 38072133)
12. Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-436.
13. Kleinberg, L., Dong, H.P., Holth, A., Risberg, B., Trope, C.G., Nesland, J.M., Flørenes, V.A., and Davidson, B. (2009). Cleaved caspases and NF-kB p65 are prognostic factors in metastatic ovarian carcinoma. Hum Pathol 40, 795-806.
14. Lee, C.H., Jeon, Y.T., Kim, S.H., and Song, Y.S. (2007). NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29, 19-35. (Pubitemid 46985299)
15. Lewander, A., Butchi, A.K., Gao, J., He, L.J., Lindblom, A., Arbman, G., Carstensen, J., Zhang, Z.Y., and Sun, X.F. (2007). Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol 42, 1332-1338. (Pubitemid 47537062)
16. Lichtenegger, W., Sehouli, J., Buchmann, E., Karajanev, C., and Weidemann, H. (1998). Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC). J Obstet Gynaecol Res 24, 447-451. (Pubitemid 29052050)
17. Lin, S.C., Liu, C.J., Yeh, W.I., Lui, M.T., Chang, K.W., and Chang, C.S. (2006). Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243, 47-54.
18. Lo, S.S., Chen, J.H., Wu, C.W., and Lui, W.Y. (2009). Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 145, 280-285.
19. Mirza, M.M., Fisher, S.A., Onnie, C., Lewis, C.M., Mathew, C.G., Sanderson, J., and Forbes, A. (2005). No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 54, 1205-1206.
20. Oliver, J., Gomez-Garcia, M., Paco, L., Lopez-Nevot, M.A., Pinero, A., Correro, F., Martin, L., Brieva, J.A., Nieto, A., and Martin, J. (2005). A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis 11, 576-579. (Pubitemid 40826345)
21. Partridge, E.E., and Barnes, M.N. (1999). Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 49, 297-320.
22. Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y. (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466. (Pubitemid 39329586)
23. Riemann, K., Becker, L., Struwe, H., Nuckel, H., Duhrsen, U., Alakus, H., Winde, G., Neuhauser, M., Rubben, H., Schmitz, K.J., Wohlschlaeger, J., Schmid, K.W., and Siffert, W. (2006). No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 16, 783-788. (Pubitemid 44632292)
24. Riemann, K., Becker, L., Struwe, H., Rubben, H., Eisenhardt, A., and Siffert, W. (2007). Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther 45, 423-430. (Pubitemid 47243938)
25. Risch, H.A., McLaughlin, J.R., Cole, D.E., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D.J., Kuperstein, G., Abrahamson, J.L., Fan, I., Wong, B., and Narod, S.A. (2001). Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68, 700-710. (Pubitemid 32203724)
26. Salvatore, C., Camarda, G., Maggi, C.A., Goso, C., Manzini, S., and Binaschi, M. (2005). NFkappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. Int J Oncol 27, 799-806.
27. Song, H., Ramus, S.J., Quaye, L., DiCioccio, R.A., Tyrer, J., Lomas, E., Shadforth, D., Hogdall, E., Hogdall, C., McGuire, V., Whittemore, A.S., Easton, D.F., Ponder, B.A., Kjaer, S.K., Pharoah, P.D., and Gayther, S.A. (2006). Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 27, 2235-2242. (Pubitemid 44644812)
28. Sumitomo, M., Tachibana, M., Ozu, C., Asakura, H., Murai, M., Hayakawa, M., Nakamura, H., Takayanagi, A., and Shimizu, N. (1999). Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. Hum Gene Ther 10, 37-47. (Pubitemid 29046144)
29. Sun, X.F., and Zhang, H. (2007). NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22, 1387-1398.
30. Sunwoo, J.B., Chen, Z., Dong, G., Yeh, N., Crowl Bancroft, C., Sausville, E., Adams, J., Elliott, P., and Van Waes, C. (2001). Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res 7, 1419-1428. (Pubitemid 32708698)
31. Tak, P.P., and Firestein, G.S. (2001). NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107, 7-11. (Pubitemid 32047405)
32. Tang, T., Cui, S., Deng, X., Gong, Z., Jiang, G., Wang, P., Liao, B., Fei, Z., Xian, S., Zeng, D., and Li, J. (2010). Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol 29, 9-12.
33. Yang, J., Pan, W.H., Clawson, G.A., and Richmond, A. (2007). Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Cancer Res 67, 3127-3134. (Pubitemid 46724849)
34. Zhou, B., Qie, M., Wang, Y., Yan, L., Zhang, Z., Liang, A., Wang, T., Wang, X., Song, Y., and Zhang, L. (2010). Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 21, 506-511.
35. Zhou, B., Rao, L., Li, Y., Gao, L., Wang, Y., Chen, Y., Xue, H., Song, Y., Peng, Y., Liao, M., and Zhang, L. (2009). A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 275, 72-76.